Viatris (Mylan Laboratories Ltd) is a global healthcare company dedicated to improving patient access to high-quality medicines, advancing sustainable practices, and developing innovative healthcare solutions. Formed through the merger of Mylan and Pfizer’s Upjohn division in 2020, Viatris operates in over 165 countries, offering a comprehensive portfolio of medicines and leveraging a robust global network.
About the Company
Mylan Laboratories Limited, part of Viatris, plays a pivotal role in delivering high-quality medicines to patients across the globe. With a commitment to affordable and sustainable healthcare, Viatris is at the forefront of improving patient outcomes.
Job Openings – Pithampur, Indore Formulation Facility
We are hiring for the Production and Quality Control departments at our Pithampur facility. Below are the details:
Production Department
Designation: Officer/Executive
Qualification: B. Pharmacy / M. Pharmacy
Experience: 2 to 6 years
Key Responsibilities:
- Manufacturing and packaging of Tablets/Capsules
- Documentation and Quality Management Systems (QMS), including Change Control, CAPA, Incident, Market Complaints
- Hands-on experience in manufacturing processes: Granulation, Compression, Coating, and Packaging
Skills Required:
- QMS, SAP, and Trackwise proficiency
Quality Control Department
Designation: Officer/Executive
Qualification: M.Sc (Chemistry) / B. Pharmacy / M. Pharmacy (Pharmaceutical Analysis)
Experience: 2 to 6 years
Key Responsibilities:
- Analysis of Raw Materials, Packaging Materials, Finished Goods, Stability, Method Transfer, and Laboratory Investigations
- Hands-on experience with HPLC, GC, Dissolution, and other instrumental analyses
Skills Required:
- QMS, SAP, LIMS, and Trackwise proficiency
Additional Information
- Candidates should be willing to work in shifts.
How to Apply
- Interested candidates are requested to send their updated resume to hr.indore@viatris.com by 24th September 2024.
- Shortlisted candidates will be invited for a personal interview in Indore on 29th September 2024. Time and venue details will be shared separately.
